Join to View Full Profile
1250 E Marshall StDept of IM OncologyhematologyRichmond, VA 23298
Phone+1 804-828-7999
Fax+1 804-828-5941
Dr. Paul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Board Certified in Internal Medicine, Medical Oncology and Hematology. Practices in VCU Medical Center, VCU Massey Cancer Center, Richmond, VA
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Rochester General HospitalResidency, Internal Medicine, 2007 - 2010
Dhaka Medical CollegeClass of 1990
Certifications & Licensure
VA State Medical License 2013 - 2026
CA State Medical License 2010 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer Start of enrollment: 2017 Nov 03
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Start of enrollment: 2018 Sep 24
- Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Start of enrollment: 2019 Jun 07
- Join now to see all
Publications & Presentations
PubMed
- HSR25-204: Clinical Characteristics and Prognosis Associated With Low PSA in Patients With De Novo Metastatic Hormone Sensitive Prostate Cancer.Bohdan Baralo, Natasha N Dziarnowski, Peter T Daniels, Cody A McIntire, Morgan M Puglisi
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Socioeconomic disparities in survival of patients with non-muscle invasive urothelial carcinoma.Bohdan Baralo, Peter T Daniels, Cody A McIntire, Rajesh Thirumaran, John W Melson
World Journal of Urology. 2025-02-12 - Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study.Alexander R Lucas, Dustin Bastiach, Bassam Dahman, Asit K Paul, Samina Hirani
Cardio-Oncology. 2025-02-06
Press Mentions
Prostate Cancer: How Family History, Gene Variants Raise the Risks for Black MenDecember 6th, 2022- Prostate Cancer and the Higher Risk for Black MenDecember 6th, 2022
Stage Four Sarcomatoid Kidney Cancer Patient First to Show Complete Response to ImmunotherapyOctober 2nd, 2018
Research History
- State University of New York, BuffaloMolecular Imaging, Antibody based targeted therapy in cancer2002 - 2007
- Osaka University Graduate School of Medicine,JapanBiomedical Imaging1997 - 2002
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
